An analysis of genetic sequencing data and gene and protein expression studies from patients with yellow nail syndrome (YNS) found that defects in the planar cell polarity (PCP) pathway play a ...
Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, has enrolled the first 16 of 32 patients in ...
Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it will receive a US$10 million milestone payment by its partner Takeda (TSE:4502/NYSE:TAK). Takeda received a national ...
The following is a summary of “Efficacy and safety of novel anticoagulant therapies in patients with chronic kidney disease—a systematic review and meta-analysis,” published in the November 2024 issue ...
Knorr Sinigang Mix brought “asim-kilig” to rainy Manila by transforming the iconic SM Mall of Asia By The Bay fountain into a giant sinigang bowl – complete with broth and traditional sinigang ...
[31] This may be a mechanism whereby antiphospholipid antibodies could predispose to WISN, although other mechanisms must also be operational. In our patient neither antiphospholipid antibodies ...